Showing results (81-90 of 285) with videos related to

Sort By:
Pageof 29
Frontiers in Oncology|February 7, 2019
PARP Inhibitors for Sensitization of Alkylation Chemotherapy in Glioblastoma: Impact of Blood-Brain Barrier and Molecular HeterogeneityShiv K Gupta, Emily J Smith, Ann C Mladek, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 2, 2019
Estrogen-related receptor β activation and isoform shifting by cdc2-like kinase inhibition restricts migration and intracranial tumor growth in glioblastomaDeanna M Tiek, Subreen A Khatib, Colin J Trepicchio, et al.
Oncogene|January 12, 2018
LPA signaling is regulated through the primary cilium: a novel target in glioblastomaYuriy V Loskutov, Caryn L Griffin, Kristina M Marinak, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|October 22, 2008
Bioluminescent imaging of intracranial vestibular schwannoma xenografts in NOD/SCID miceBrian A Neff, Stephen G Voss, Cory Allen, et al.
Molecular Medicine (Cambridge, Mass.)|November 16, 2019
Inhibition of phosphatidylinositol 3-kinase by PX-866 suppresses temozolomide-induced autophagy and promotes apoptosis in glioblastoma cellsBryan G Harder, Sen Peng, Christopher P Sereduk, et al.
Genomics, Proteomics & Bioinformatics|September 26, 2024
Identify Non-mutational p53 Functional Deficiency in Human CancersQianpeng Li, Yang Zhang, Sicheng Luo, et al.
Cell Reports. Medicine|June 19, 2024
The impact of ATP-binding cassette transporters in the diseased brain: Context mattersChrysiida Baltira, Eleonora Aronica, William F Elmquist, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 26, 2015
Factors Influencing the Central Nervous System Distribution of a Novel Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Inhibitor GSK2126458: Implications for Overcoming Resistance with Combination Therapy for Melanoma Brain MetastasesShruthi Vaidhyanathan, Brynna Wilken-Resman, Daniel J Ma, et al.
International Journal of Radiation Oncology, Biology, Physics|August 8, 2013
Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT)Brandon M Barney, Svetomir N Markovic, Nadia N Laack, et al.
Advanced Therapeutics|April 18, 2025
Targeting glioblastoma tumor hyaluronan to enhance therapeutic interventions that regulate metabolic cell propertiesEdward R Neves, Achal Anand, Joseph Mueller, et al.
Pageof 29